BeStock  
Stocks › Biotechnology › MNPR

Monopar Therapeutics MNPR

US equityMarket cap rank #3617Biotechnology
$69.00 −$1.29 (-1.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $67.35 -2.40%
Open$68.50
Prev close$70.29
Day range$67.36 – $69.86
Volume132.6K
Market cap$467.60M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-29.5x
CheapRich

Near the bottom of its 5-year range · 12th percentile, 5-year average -10.5x

Price / book3.8x
CheapRich

Above its usual level · 74th percentile, 5-year average 5.5x

#4083 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-65x-41x-16x8xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$88.91
Price vs. fair value-22.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.84 – 5.49 74% (pricier than usual) #4083 of 5329 (1 = cheapest)
PE -29.51 -9.98 -10.55 12% (cheaper than usual) –
PS – 121.26 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on MNPR.

Sign in to join the discussion.

Scroll to Top